Vectus Biosystems Ltd
ASX:VBS
Balance Sheet
Balance Sheet Decomposition
Vectus Biosystems Ltd
Vectus Biosystems Ltd
Balance Sheet
Vectus Biosystems Ltd
| Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
0
|
3
|
0
|
1
|
0
|
0
|
3
|
6
|
1
|
3
|
1
|
0
|
|
| Cash |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
6
|
1
|
3
|
1
|
0
|
|
| Cash Equivalents |
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
1
|
3
|
5
|
1
|
0
|
0
|
3
|
7
|
4
|
4
|
2
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
+122%
|
1
-52%
|
3
+274%
|
5
+74%
|
1
-85%
|
0
-73%
|
0
-1%
|
3
+1 445%
|
7
+133%
|
4
-44%
|
5
+18%
|
2
-56%
|
1
-61%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
0
|
1
|
1
|
2
|
2
|
1
|
2
|
7
|
1
|
1
|
1
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
7
|
7
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
-56%
|
1
+27%
|
1
-23%
|
1
+83%
|
1
-35%
|
2
+306%
|
4
+60%
|
9
+120%
|
9
+3%
|
7
-18%
|
1
-88%
|
1
-37%
|
1
+93%
|
|
| Equity | |||||||||||||||
| Common Stock |
6
|
9
|
9
|
13
|
18
|
18
|
18
|
18
|
18
|
25
|
27
|
38
|
38
|
38
|
|
| Retained Earnings |
6
|
8
|
9
|
11
|
14
|
17
|
20
|
21
|
25
|
28
|
31
|
35
|
37
|
39
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
1
N/A
|
0
-94%
|
2
+3 533%
|
4
+72%
|
0
-97%
|
2
N/A
|
4
-65%
|
6
-51%
|
2
+67%
|
3
-75%
|
4
N/A
|
1
-61%
|
0
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+122%
|
1
-52%
|
3
+274%
|
5
+74%
|
1
-85%
|
0
-73%
|
0
-1%
|
3
+1 445%
|
7
+133%
|
4
-44%
|
5
+18%
|
2
-56%
|
1
-61%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
22
|
22
|
22
|
22
|
23
|
23
|
23
|
23
|
24
|
32
|
36
|
53
|
53
|
53
|
|